VC-Backed Startups May Have Advantage Over Other Firms If User Fees Pass
This article was originally published in The Gray Sheet
Executive Summary
Venture capital-backed medical device developers would sustain a muted impact from having to pay user fees for 510(k)s and PMAs compared with their non-venture-backed counterparts, speakers agreed at the Medical Device Manufacturers Association annual meeting May 23 in Washington, D.C